Internal Medicine, Endocrinology, Diabetes, & Metabolism · Springfield, IL
NPI
1174510978
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1118 Legacy Pointe Dr
Springfield, IL, 62711
Phone (217) 787-8870
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
3,168 services
Medicare patients, 2024
424
Average age 72
Drug cost, 2024
$3.7M
8,370 prescriptions
Company payments, 2025
$1,230
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marina K Russo was code J0897 (injection, denosumab, 1 mg), 1,140 times for 12 patients. In total Marina K Russo billed 3,168 services in 15 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,140 | 12 | $20.66 | $24K |
| 83036 Blood Count | Office | 514 | 286 | $9.49 | $4,878 |
| 99214 Office E&M - Established | Office | 458 | 293 | $90.08 | $41K |
| 82962 Clinical Chemistry | Office | 386 | 253 | $3.21 | $1,239 |
| 95251 Test - Miscellaneous | Office | 262 | 139 | $26.79 | $7,018 |
| 99213 Office E&M - Established | Office | 209 | 173 | $66.16 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 63 | 61 | $12.33 | $777 |
| 99204 Office E&M - New | Office | 49 | 49 | $121.47 | $5,952 |
| 36415 Venipuncture Blood Collection | Office | 39 | 36 | $8.65 | $337 |
| 99203 Office E&M - New | Office | 25 | 25 | $82.98 | $2,075 |
| 96372 Injection Administration | Office | 19 | 12 | $11.35 | $216 |
By year: 2022 $84K for 2,884 services; 2023 $95K for 3,177 services; 2024 $101K for 3,168 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 514 | 286 | $9.49 | $4,878 |
| 82962 Clinical Chemistry | 386 | 253 | $3.21 | $1,239 |
| 36415 Venipuncture Blood Collection | 39 | 36 | $8.65 | $337 |
Medicare prescription drug claims, 2024
In 2024, the drug Marina K Russo prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 568 prescriptions and refills. In total Marina K Russo wrote 8,370 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Er Metformin Hcl | 568 | 1,486 | 163 | $5,698 |
| Ozempic Semaglutide | 566 | 1,028 | 134 | $1.0M |
| Glipizide Generic | 540 | 1,412 | 148 | $3,600 |
| Pioglitazone Hcl Generic | 495 | 1,308 | 133 | $5,087 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 369 | 709 | 98 | $53K |
| Levothyroxine Sodium Generic | 369 | 984 | 107 | $3,110 |
| Metformin Hcl Generic | 331 | 903 | 108 | $2,350 |
| Glipizide Er Glipizide | 320 | 831 | 85 | $3,805 |
| Mounjaro Tirzepatide | 293 | 435 | 73 | $464K |
| Glimepiride Generic | 235 | 658 | 66 | $2,775 |
| Farxiga Dapagliflozin Propanediol | 231 | 511 | 60 | $284K |
| Tresiba Flextouch U-100 Insulin Degludec | 198 | 361 | 51 | $155K |
| Jardiance Empagliflozin | 197 | 347 | 38 | $200K |
| Novolog Flexpen Insulin Aspart | 164 | 287 | 53 | $34K |
| Humalog Kwikpen U-100 Insulin Lispro | 153 | 285 | 44 | $46K |
Brand drugs: 3,965 claims; generic drugs: 3,787 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marina K Russo $1,230 ($1,230 in general payments such as food, travel and fees) from 23 companies. The largest payer was Insulet Corporation with $149.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 1 | $149 |
| Amgen Inc. AMGN | 6 | $112 |
| Recordati_rare_diseases_inc. | 4 | $109 |
| Novo Nordisk Inc NVO | 4 | $84.57 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $75.4 |
| Sandoz Inc. SDZ.SW | 3 | $63.18 |
| Corcept Therapeutics CORT | 2 | $60.26 |
| Lilly USA, LLC LLY | 3 | $58.45 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $56.16 |
| Sequel Med Tech, LLC | 2 | $54.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.